Collagen Matrix, Inc. Announces 510(k) Clearance for Fibrillar Collagen Wound Dressing, Expanding Offerings for Advanced Wound Market

OAKLAND, NJ — 6/28/22 — Collagen Matrix, Inc., a leader in regenerative medicine, global manufacturer of collagen and other biomaterial-based medical devices, and Linden Capital Partners portfolio company (“Collagen Matrix” or “the Company”), announced today its 510(k) Clearance for a new Fibrillar Collagen Wound Dressing. Marking the 40th 510(k) in the Company’s history, this approval…

Read More

Collagen Matrix, Inc., appoints Wendell Raddatz as Vice President of Strategic Alliances

OAKLAND, NJ – 5/2/22 – Collagen Matrix, Inc., a leader in regenerative medicine, global manufacturer of collagen- and mineral-based medical devices, and Linden Capital Partners portfolio company, announced today the appointment of Wendell Raddatz as Vice President, Strategic Alliances. Wendell joins Collagen Matrix after an extensive career in sales and business development with leading manufacturers…

Read More

Collagen Matrix Names Timothy J. Scannell to its Board of Directors

Collagen Matrix Inc., a leader in regenerative medicine, global manufacturer of collagen and mineral-based medical devices, and Linden Capital Partners portfolio company, announced today the appointment of Timothy J. Scannell to its board of directors. A seasoned and dynamic medical device leader, Mr. Scannell most recently served as President and Chief Operating Officer of Stryker.…

Read More

Collagen Matrix Names Tony Orsini Chief Operating Officer

Collagen Matrix, Inc., a leader in regenerative medicine, global manufacturer of collagen- and mineral-based medical devices, and Linden Capital Partners portfolio company, announced today the appointment of Tony Orsini as Chief Operating Officer. Tony has an extensive background in operations and team leadership, most recently serving as Chief Operating Officer at Flexan, a leader in…

Read More

Collagen Matrix Acquires Sunstar’s GUIDOR® Synthetic Bone Graft & Membrane Business

Collagen Matrix, Inc., a global leader in regenerative, collagen-based, xenograft-derived medical devices, and portfolio company of Linden Capital Partners (“Linden”), announced today the acquisition of Sunstar’s Degradable Solutions division (the “Company”), including its GUIDOR® branded line of resorbable synthetic medical implants. Founded in 1999, Degradable Solutions AG, is headquartered in Schlieren, Switzerland, and has been part…

Read More

Collagen Matrix, Inc. Receives FDA 510(k) Clearance of a Bioactive Moldable Bone Graft Matrix

Collagen Matrix, Inc., a leader in regenerative medicine and a global manufacturer of collagen and mineral based medical devices announced today the FDA 510(k) clearance of its innovative line of Mineral Collagen Composite Bioactive Moldable Bone Graft Matrix through its Spine business unit. OssiMend® Bioactive Moldable Bone Graft Matrix is a perfect trio of anorganic…

Read More

Collagen Matrix Launches OssiMend® Spine and DuraMatrix® Dural Repair Products in Asia

Collagen Matrix, Inc., a leader in regenerative medicine and a global manufacturer of collagen and mineral based medical devices announced today its first entrance into the India market with two product lines, OssiMend® bone graft matrices from its Spine Business Unit and DuraMatrix®membranes from its Dural Repair Business Unit. OssiMend® bone graft matrices are designed…

Read More

Collagen Matrix Celebrates 20 Years of Science, Technology and Innovation

It started with an idea that transformed into a success story, 20 years in the making. Today, Collagen Matrix, celebrating its 20th anniversary, has developed collagen and mineral based medical devices that have helped patients worldwide with over 7.5 million products sold. The Company has grown from a start-up business with a handful of employees…

Read More

Shu-Tung Li to be Inducted Into The AIMBE College of Fellows

Collagen Matrix, Inc., the driving force in the design, development and manufacturing of collagen and mineral based medical devices for tissue repair and regeneration announced today that Shu-Tung Li, Ph.D., Founder and Chief Scientific Officer of the Company will be inducted by The American Institute for Medical and Biological Engineering (AIMBE) into its College of…

Read More

Collagen Matrix, Inc. Selected to Participate in FDA’s Experiential Learning Program

Collagen Matrix, Inc., a leading provider of high quality products and technology used in tissue repair and regeneration announced today it has been selected to participate in the Food and Drug Administration’s Experiential Learning Program (ELP).  The ELP is designed to provide the FDA’s Center for Devices and Radiological Health (CDRH) review staff with real-world…

Read More